EUCTR2008-007670-37-AT进行中（未招募）不适用
Exploratory study of S 38093 versus placebo in patients with mild to moderate Alzheimer’s Disease.An international, multi-centre, randomised, double-blind, placebo-controlled phase IIa study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- age 55-85 years (inclusive),
- •- male or female,
- •- with cognitive impairment, MMSE 15-26 (inclusive), Clinical Dementia Ratings global score > or = 0.5 (memory sub-score > or = 1.0)
- •- out-patients, defined for the present study as ambulatory or ambulatory with aids,
- •- with a minimum of 5 years of school education,
- •- with a caregiver.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Dementia due to any condition other than Alzheimer's Disease,
- •- History or presence of Parkinson’s disease or Parkinsonism,
- •- Cerebral vascular disorders (stroke, TIA, etc.),
- •- Epilepsy or solitary seizure
- •- Advanced, severe, progressive,, or unstable disease of any type that could interfere with safety and efficacy assessments or put the patient at particular risk.
研究者
相似试验
进行中（未招募）
不适用
Exploratory study of S 38093 versus placebo in patients with mild to moderate Alzheimer’s Disease.An international, multi-centre, randomised, double-blind, placebo-controlled phase IIa study.Alzheimer's diseaseEUCTR2008-007670-37-GBInstitut de Recherches Internationales Servier200
进行中（未招募）
不适用
Exploratory study of S 38093 versus placebo in patients with mild to moderate Alzheimer’s Disease.An international, multi-centre, randomised, double-blind, placebo-controlled phase IIa study.MedDRA version: 9.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseAlzheimer's diseaseEUCTR2008-007670-37-DEInstitut de Recherches Internationales Servier200
已完成
不适用
A phase III placebo-controlled comparative study of SJP-0118 in patients with bacterial conjunctivitisbacterial conjunctivitisJPRN-UMIN000027039Senju Pharmaceutical Co., Ltd.640
已完成
不适用
Efficacy of EPs 7630 compared to placebo in the treatment of acute bronchitisBronchitisAcute bronchitisRespiratoryISRCTN60790910ISO Arzneimittel GmbH & Co KG (Germany)205
终止
3 期
WP-1303 Phase 3 combination studyprimary open-angle glaucoma, ocular hypertensionJPRN-jRCT2080224837Wakamoto pharmaceutical Co., Ltd.280